Foghorn Therapeutics Inc. (FHTX) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$74.28M | +14.2% |
| 2024 | -$86.62M | +12.0% |
| 2023 | -$98.43M | +9.6% |
| 2022 | -$108.88M | -7.5% |
| 2021 | -$101.32M | -47.3% |
| 2020 | -$68.80M | -34.6% |
| 2019 | -$51.13M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$74.28M | +14.2% |
| 2024 | -$86.62M | +12.0% |
| 2023 | -$98.43M | +9.6% |
| 2022 | -$108.88M | -7.5% |
| 2021 | -$101.32M | -47.3% |
| 2020 | -$68.80M | -34.6% |
| 2019 | -$51.13M | — |